Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy

Withdrawn before enrolling · Phase 4

Conditions studied: Contrast Induced Nephropathy

In brief

The increased risk for contrast-induced nephropathy (CIN) in patients with chronic kidney disease (CKD) undergoing coronary angiography (CAG) has been established. Current and historical data on CIN prevention strategies have shown wide variation with respect to the optimal type, route and timing of these therapies. We investigate the role for oral hydration and/or oral sodium bicarbonate administration compared to intravenous hydration and/or sodium bicarbonate in patients with CKD undergoing CAG.

Key facts

Study ID
NCT01093131
Run by
The Western Pennsylvania Hospital
People needed
0
Starts
2005-02-01
Expected to finish
2010-02-01
Last updated by the study team
2019-10-04

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.